- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05051189
Effect of Opioids on Central Control of Ventilation in Children With Obstructive Sleep Apnea
April 18, 2024 updated by: Adam Adler MD, MS, FAAP, Baylor College of Medicine
Children OSA exhibit varying responses to opioids.
It is unknown if the degree of intermittent hypoxemia results in different opioid sensitivity
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Ventilatory suppression in children following opioid administration is of obvious concern, especially following routine surgical procedures (i.e.
adenotonsillectomy).
It is thought that patients with obstructive sleep apnea (OSA) have increased sensitivity to opioids, and especially in opioid naïve patients.
Recent evidence in children suggests that patients with moderate to severe OSA may not predispose patients to increased opioid sensitivity in the form of respiratory depression when compared with patients that do not have OSA.
However, what is not known is wether the degree of hypoxemia experienced by patients effects the opioid sensitivity.
The aim of this study is to identify if children with known OSA experience a difference in opioid induced respiratory depression based on the degree of hypoxemia.
Study Type
Interventional
Enrollment (Estimated)
130
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Recruiting
- Texas Childrens Hospital
-
Contact:
- Adam Adler, MD
- Phone Number: 832-824-5800
- Email: axadler@texaschildrens.org
-
Contact:
- Kim Mayfield
- Phone Number: 8328245800
- Email: kxmayfie@texaschildrens.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 8 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients undergoing tonsillectomy or adenotonsillectomy
- Ages 2 to up to 8 years
- Preoperative sleep study demonstrating obstructive sleep apnea
- Intubation without medication (e.g. no propofol prior to intubation)
- Requirement for airway instrumentation: LMA or ETT
- Inhalation induction of anesthesia
Exclusion Criteria:
- No obstructive sleep apnea
- Central sleep apnea events >5/hour
- IV induction of anesthesia
- Syndromic patients
- Known or suspected difficult airway
- Allergy to Fentanyl
- Known cardiovascular medications
- Pulmonary hypertension
- Total intravenous anesthesia required
- Parental refusal
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Patients with sleep apnea having oxygen Saturation >85%
Children with OSA having procedures requiring endotracheal intubation and an who will receive opioids for evaluation of respiratory changes
|
Ventilatory response to fentanyl in patients with OSA Specifically: respiratory changes, CO2, RR, TV
|
Active Comparator: Patients with sleep apnea having oxygen Saturation <85%
Children without OSA having procedures requiring endotracheal intubation and an who will receive opioids for evaluation of respiratory changes
|
Ventilatory response to fentanyl in patients with OSA Specifically: respiratory changes, CO2, RR, TV
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Respiratory depression following opioids
Time Frame: respiratory rate measured at each minute for 10 consecutive minutes following opioid administration
|
Identification of respiratory depression following fentanyl administration by recording the respiratory rate prior to and 10 minutes following fentanyl administration
|
respiratory rate measured at each minute for 10 consecutive minutes following opioid administration
|
Respiratory depression following opioids
Time Frame: tidal volume measured at each minute for 10 consecutive minutes following opioid administration
|
Identification of respiratory depression following fentanyl administration by recording the tidal volume prior to and 10 minutes following fentanyl administration
|
tidal volume measured at each minute for 10 consecutive minutes following opioid administration
|
Respiratory depression following opioids
Time Frame: end tidal co2 measured at each minute for 10 consecutive minutes following opioid administration
|
Identification of respiratory depression following fentanyl administration by recording the end-tidal co2 prior to and 10 minutes following fentanyl administration
|
end tidal co2 measured at each minute for 10 consecutive minutes following opioid administration
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2021
Primary Completion (Estimated)
November 1, 2024
Study Completion (Estimated)
November 1, 2024
Study Registration Dates
First Submitted
September 2, 2021
First Submitted That Met QC Criteria
September 9, 2021
First Posted (Actual)
September 21, 2021
Study Record Updates
Last Update Posted (Actual)
April 19, 2024
Last Update Submitted That Met QC Criteria
April 18, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Nervous System Diseases
- Respiratory Tract Diseases
- Apnea
- Respiration Disorders
- Sleep Disorders, Intrinsic
- Dyssomnias
- Sleep Wake Disorders
- Sleep Apnea Syndromes
- Sleep Apnea, Obstructive
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Analgesics, Opioid
- Narcotics
- Adjuvants, Anesthesia
- Fentanyl
Other Study ID Numbers
- H50267
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
De-identified data will be made available at the conclusion of the study upon reasonable written request to the PI
IPD Sharing Time Frame
De-identified raw data will be available upon study completion following written request to the PI.
There will be no time restriction on data
IPD Sharing Access Criteria
Written request
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on OSA
-
Biocubica srlRecruiting
-
Brigham and Women's HospitalRecruiting
-
Brigham and Women's HospitalRecruiting
-
Woolcock Institute of Medical ResearchFullpower Technologies, Inc.Not yet recruiting
-
Chang Gung Memorial HospitalUnknown
-
Mahidol UniversityUnknownOSA | ComplicationThailand
-
Changi General HospitalCompleted
-
VA Office of Research and DevelopmentRecruitingOSA | COPDUnited States
Clinical Trials on Fentanyl Citrate
-
Samuel Lunenfeld Research Institute, Mount Sinai...Terminated
-
Kyowa Kirin Co., Ltd.Completed
-
Nationwide Children's HospitalCompletedTetralogy of Fallot (TOF) | Ventricular Septal Defects (VSD) | Atrioventricular Septal Defects (AVSD)United States
-
University of Maryland, BaltimoreFood and Drug Administration (FDA)Completed
-
Beni-Suef UniversityUnknown
-
INSYS Therapeutics IncCompleted
-
Archimedes Development LtdCompleted
-
INSYS Therapeutics IncCompleted
-
Archimedes Development LtdCompleted
-
Lung Biotechnology PBCTerminatedPulmonary Arterial HypertensionUnited States, Israel